Anzeige
❌
Mehr »
Montag, 26.10.2026 - Börsentäglich über 12.000 News
25+ Jahre Tiefsee-Erfahrung: Wie Ölexperten für SEAS den Abbau von Meeresbodenmineralien vorantreiben
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
IM

WKN: A41XT7 | ISIN: KYG4790P1037 | Ticker-Symbol: O15
Tradegate
26.10.26 | 16:58
4,180 Euro
+1,46 % +0,060
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
INSILICO MEDICINE CAYMAN TOPCO Chart 1 Jahr
5-Tage-Chart
INSILICO MEDICINE CAYMAN TOPCO 5-Tage-Chart
RealtimeGeldBriefZeit
4,1404,22019:22
4,1804,20016:59

Aktuelle News zur INSILICO MEDICINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:00Insilico Medicine Reports 40% ORR at 130 mg for Pan-TEAD Inhibitor ISM6331 Designed Using Generative AI in Heavily Pretreated Mesothelioma at ESMO 202676.release-content span.prnews_span{font-size:8pt;font-family:"Arial";color:black}.release-content a.prnews_a{color:blue}.release-content li.prnews_li{font-size:8pt;font-family:"Arial";color:black}.release-content...
► Artikel lesen
DiInsilico Medicine and Servier Achieve First Milestone in AI-Driven R&D Collaboration, Triggering An undisclosed Milestone Payment2.075Two programs under the multi-year R&D collaboration have initiated and completed target nomination since its early 2026 announcement. Insilico reached the first...
► Artikel lesen
DiINSILICO (03696): VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE TRIGGERS A MILESTONE PAYMENT IN AI-DRIVEN R&D COLLABORATION WITH SERVIER FOR ACHIEVING EARLY ...4
13.10.INSILICO Nominates VAV1 Molecular Glue Degrader ISM9546 as Preclinical Candidate24
13.10.INSILICO (03696): VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE NOMINATES PERIPHERAL-RESTRICTED VAV1 MOLECULAR GLUE DEGRADER FOR POTENTIAL TREATMENT OF AUTOIMMUNE ...15
INSILICO MEDICINE Aktie jetzt für 0€ handeln
07.10.Crypto.com integrates Insilico Terminal to deliver professional-grade trading tools10
30.09.INSILICO Nominates Next-Generation Small Molecule GIPR Antagonist15
30.09.INSILICO (03696): VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE NOMINATES NEXT-GENERATION SMALL MOLECULE GIPR ANTAGONIST FOR POTENTIAL INTERVENTION OF OBESITY ...30
21.09.Insilico Jumps After Signing Deal to Develop Biology AI Models Worth Tens of Millions of US Dollars7
21.09.INSILICO (03696): VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE ENTERED INTO AN AI CO-DEVELOPMENT COLLABORATION WITH A CONTRACT VALUE UP TO TENS OF MILLIONS ...3
18.09.Insilico Medicine's Alex Zhavoronkov bets China and AI can deliver the drug industry's next breakthrough6
14.09.Insilico Medicine's Rentosertib Shows Potential Biological Age Reversal Across Six Proteomic Aging Clocks3
14.09.INSILICO (03696): VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD1
10.09.Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug766CAMBRIDGE, Mass., Sept. 9, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today...
► Artikel lesen
10.09.INSILICO (03696): VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE COMPLETED FIRST PATIENT ENROLLMENT AND DOSING IN PHASE III (GENESIS-IPF-3) CLINICAL TRIAL OF ...1
09.09.Insilico's co-CEO hopes 'we might have a chance to stop biological aging' after promising results from its fibrosis drug trial2
08.09.KI-Pharmasparte: Citi kürt Insilico zum Top-Pick in China16
04.09.INSILICO (03696): VOLUNTARY ANNOUNCEMENT SHARE INCREASING PLAN BY THE CHAIRMAN OF THE BOARD5
03.09.INSILICO (03696): COMPLETION OF THE ISSUE OF US$305,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2027 UNDER GENERAL MANDATE2
28.08.INSILICO (03696): PRICING OF US$305,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 20275
1 2 3 4 5 Weiter >>
89 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2